Download DNB 2019 June GASTROENTEROLOGY GASTROENTEROLOGY PAPER 3 Question Paper

FirstRanker.com

FINAL EXAM

JUNE 2019

--- Content provided by FirstRanker.com ---

Time: 3 hours

GASTROENTEROLOGY

PAPER-III

Max. Marks: 100

Important Instructions:

--- Content provided by‌ FirstRanker.com ---

• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.

--- Content provided by FirstRanker.com ---

• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate

Write short notes on:

1. a) Newer therapies for Chronic Hepatitis C. (3+3+2+2)
   

   --- Content provided by⁠ FirstRanker.com ---

   b) Treatment of Chronic Hepatitis C in chronic kidney diseases.
   c) Immune escape phenomenon in Hepatitis C infection.
   d) Drug resistance in Chronic Hepatitis C.
2. a) POEM Vs Pneumatic Dilatation in Achalasia Cardia. (4+3+3)
   b) Endoscopic Vs Surgical drainage in Walled off Necrosis.

--- Content provided by FirstRanker.com ---

3. a) Endoscopic Vs Surgical treatment of Barrett's Esophagus. (4+3+3)
   b) Role of simulators in training and teaching in GI Endoscopy.
4. a) Confocal Endoscopy. (3+4+3)
   b) Narrow Band Imaging.
5. a) Gut microbiota in inflammatory bowel disease (IBD). (5+5)
   

   --- Content provided by FirstRanker.com ---

   b) Fecal microbiota transplant in liver diseases.
6. a) GLP-1 therapy in IBD. (5+5)
   b) Approach to a case of cystic lesions of pancreas.
7. a) Role of EUS in diagnosis and treatment of pancreatic diseases. (5+5)
   b) Newer drugs in pipeline for treatment of Chronic Hepatitis B.

--- Content provided by‌ FirstRanker.com ---

8. a) Role of intestinal and epithelial TLR5 in metabolic syndrome. (4+3+3)
   b) Genomic profiling in targeted therapy in biliary cancers.
   c) Role of proteases in GI diseases.
9. a) Role of EUS in management of biliary tract diseases. (5+5)
   b) Applications of radiofrequency ablation in GI cancers.

--- Content provided by⁠ FirstRanker.com ---

10. a) Hepatic regeneration and its clinical implications. (4+3+3)
    b) Biological markers for liver fibrosis.
    c) Biosimilars in IBD.

Status of vaccine for Hepatitis E.

Enteric duplication cysts.

--- Content provided by FirstRanker.com ---

Abdominal cocoon.

POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.

FirstRanker.com